News

News

DailyMed Announcements

Posted: March 23, 2020

DailyMed Testing Static IP Removal


Now live - 04/06/2020: DailyMed is using dynamic IP addresses.

DailyMed is migrating to cloud services later this year and will be moving away from static IP addresses during this process. In preparation of this change, DailyMed will temporarily remove its static IP addresses and move to dynamic IP addresses for a week starting on 04/06/2020 and ending on 04/10/2020.

During this period, if you encounter any issues please let us know by contacting the NLM Support Center for further assistance.
If you know you will be impacted by this change, or you have any other concerns or issues, please contact customer support.

Posted: March 23, 2020

Information About Regulatory Changes for Certain Biological Product Medications Beginning on March 23, 2020

On March 23, 2020, the Biologics Price Competition and Innovation Act of 2009 requires that an approved application for a “biological product” under section 505 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) shall be deemed to be a license for the biological product (i.e., an approved Biologics License Application (BLA)) under section 351 of the Public Health Service Act (PHS Act). FDA has assigned...

Get RSS News & Updates

The DailyMed RSS feed provides updates and information about new drug labels approved by the FDA and published on NLM's DailyMed Web site.

About DailyMed

About DailyMed

DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts). This Web site provides a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling found in medication package inserts.

The National Library of Medicine (NLM) provides this as a public service and does not accept advertisements. The drug labeling information on this Web site is the most recent submitted to the Food and Drug Administration (FDA) and currently in use; it may include, for example, strengthened warnings undergoing FDA review or minor editorial changes. These labels have been reformatted to make them easier to read.